Immunoassay Bioanalysis Service

ResolianAvailable: Worldwide

Immunogenicity bioanalysis solutions for pre-clinical and clinical assessments.

Resolian

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Write your own review

Immune responses to therapeutic products have the potential to affect Pharmacokinetics (PK), Pharmacodynamics (PD), safety and efficacy. Assessment of a biotherapeutics' ability to produce an immune response requires the development of customized immunoassays following a tiered approach. With a specialized team of scientists and regulatory project managers we have a wealth of experience in developing and validating sensitive, specific, selective, and drug/target tolerant ADA and NAbs assays to support non-clinical and clinical immunogenicity up to Phase IV post-marketing surveillance. All validation is performed to GCP or GLP standards in line with current regulations (FDA and/or EMA).

Product Overview

Links